NCT05368324

Brief Summary

The main aim is to know the effectiveness of a program, CogFun-VR, through the use of immersive virtual reality, to improve executive skills, such as self-regulation, organization, planning and time management in life. of children and adolescents with ADHD, between 9 and 16 years old. The study design is a randomized clinical trial, with a control group on a waiting list. The estimated sample size is 82 participants: 41 in the experimental group and 41 in the control group. Participants will be randomly assigned to one of the two groups. Four measurements of the variables of interest will be conducted, in the beginning, after the 12-week duration of the intervention, at 3 months and 6 months as a follow-up. The BRIEF, SNAP-IV, SDQ, EQi: YV and several subtests of the WISC-%, BADS and NEPSY-II will be used. All participants will be assessed by an independent evaluator who will be blinded. The intervention program is manualized to assess its integrity and reliability.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
82

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jun 2022

Typical duration for not_applicable

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 1, 2022

Completed
9 days until next milestone

First Posted

Study publicly available on registry

May 10, 2022

Completed
22 days until next milestone

Study Start

First participant enrolled

June 1, 2022

Completed
2.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 28, 2024

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 13, 2024

Completed
Last Updated

May 20, 2022

Status Verified

May 1, 2022

Enrollment Period

2.1 years

First QC Date

May 1, 2022

Last Update Submit

May 16, 2022

Conditions

Outcome Measures

Primary Outcomes (6)

  • Weiss Functional Impairment Rating Scale-Parent Form for assessing ADHD

    The Weiss Functional Impairment Rating Scale- Parent Form (WFIRS-P) is a 50-item scale that assesses functional impairment on six clinically relevant domains typically affected in attention-deficit/hyperactivity disorder (ADHD)

    After the Intervention (12 weeks)

  • Weiss Functional Impairment Rating Scale-Parent Form for assessing ADHD

    The Weiss Functional Impairment Rating Scale Parent Form (WFIRS-P) is a 50-item scale that assesses functional impairment on six clinically relevant domains typically affected in attention-deficit/hyperactivity disorder (ADHD)

    At 3 months

  • Weiss Functional Impairment Rating Scale-Parent Form for assessing ADHD

    The Weiss Functional Impairment Rating Scale- Parent Form (WFIRS-P) is a 50-item scale that assesses functional impairment on six clinically relevant domains typically affected in attention-deficit/hyperactivity disorder (ADHD)

    At 6 months

  • Self-assessment of daily time management in children (TIME-S)

    Self-assessment for children with disabilities ages 10-17 ability of time perception, time orientation andknowledge on time management in children 10-17 years old

    After the intervention: 12 weeks

  • Self-assessment of daily time management in children (TIME-S)

    Self-assessment for children with disabilities ages 10-17 ability of time perception, time orientation andknowledge on time management in children 10-17 years old

    At 3 months

  • Self-assessment of daily time management in children (TIME-S)

    Self-assessment for children with disabilities ages 10-17 ability of time perception, time orientation andknowledge on time management in children 10-17 years old

    At 6 months

Secondary Outcomes (8)

  • Assessment of Executive Function and Sensory Processing (EPYFEI)

    Before and after the intervention (12 weeks)

  • Conners Behavior Questionnaire for Parents (SNAP-IV)

    Before and after the intervention (12 weeks)

  • Zoo Map Subtest

    Before and after the intervention (12 weeks)

  • Stroop Test

    Before and after the intervention (12 weeks)

  • Trail Making Test

    Before and after the intervention (12 weeks)

  • +3 more secondary outcomes

Study Arms (2)

CogFun-RV

EXPERIMENTAL

It consists of 12 sessions, each lasting 75 minutes for each children. Parallel parents will participate in the parental guidance and psychoeducation program with one of the two therapists assigned to the child.

Behavioral: CogFun-RV

Control group on waiting list

OTHER

After 6 months, the participants of the control group on the waiting list will be invited to participate if the results of the analysis show positive effects of the intervention.

Behavioral: CogFun-RV

Interventions

CogFun-RVBEHAVIORAL

CogFun-RV intervention combines training in daily living skills, organization, task planning, time organization, emotional regulation, self-esteem and mindfulness in children and the parents. It consists of 12 sessions, each lasting 75 minutes. Parents will participate in the parental guidance and psychoeducation program with one of the two therapists assigned to the child. As it is a program of a simultaneous nature, excessive impact on the daily life of families is avoided. All sessions will be carried out individually.

CogFun-RVControl group on waiting list

Eligibility Criteria

Age9 Years - 17 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Age between 9 and 17 years
  • Clinical diagnosis of ADHD
  • With stable pharmacological treatment

You may not qualify if:

  • Children with disorders comorbid with ASD and severe behavioural disorders
  • With other non-pharmacological treatments
  • That they start a new pharmacological or non-pharmacological treatment during the duration of the study (they will not be considered for the analysis of the results).
  • Have visual deficits that prevent the use of virtual reality glasses
  • Present symptoms of Cybersickness

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Attention Deficit Disorder with Hyperactivity

Condition Hierarchy (Ancestors)

Attention Deficit and Disruptive Behavior DisordersNeurodevelopmental DisordersMental Disorders

Central Study Contacts

Dulce Romero-Ayuso, PhD

CONTACT

José M Triviño-Juárez, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
INVESTIGATOR, OUTCOMES ASSESSOR
Masking Details
All participants will be evaluated by an independent evaluator who will be blinded. The statistician will also be blinded, will not participate in the evaluation or intervention. For analysis it will only be revealed as group A or group B. Only when the analyzes have been completed will the exact nature of the groups be revealed.
Purpose
TREATMENT
Intervention Model
SEQUENTIAL
Model Details: Randomized clinical trial, with a control group on the waiting list.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

May 1, 2022

First Posted

May 10, 2022

Study Start

June 1, 2022

Primary Completion

June 28, 2024

Study Completion

December 13, 2024

Last Updated

May 20, 2022

Record last verified: 2022-05

Data Sharing

IPD Sharing
Will not share